Vaginal CO(2) laser therapy for genitourinary syndrome in breast cancer survivors—VagLaser study protocol: a randomized blinded, placebo-controlled trial

BACKGROUND: Vaginal CO(2) laser therapy is a new treatment option for genitourinary syndrome of menopause. Its potential is particularly interesting in breast cancer survivors, where existing treatment options often are insufficient as hormonal treatment is problematic in these women. The objective...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobsen, Sine, Glavind-Kristensen, Marianne, Jensen, Anders Bonde, Forman, Axel, Bor, Pinar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685468/
https://www.ncbi.nlm.nih.gov/pubmed/38031020
http://dx.doi.org/10.1186/s12885-023-11656-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685468/
https://www.ncbi.nlm.nih.gov/pubmed/38031020
http://dx.doi.org/10.1186/s12885-023-11656-x

Ejemplares similares